Highlights Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
0.179 ^USD	-0.50%		+18.54%	-90.16%

Jun. 03	Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	MT
Jun. 03	Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	Jun. 03	MT
Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	Jun. 03	MT
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	Apr. 15	CI
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	Apr. 12	CI
Portage Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 28	CI
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 28	CI
Portage Biotech Inc. Presents Updates on its iNKT and Adenosine Programs at the Society for Immunotherapy of Cancer's 38th Annual Meeting	Nov. 06	CI
Portage Biotech Inc. Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with Keytruda®? (Pembrolizumab) in Solid Tumors	23-09-05	CI
Portage Biotech Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-29	CI
Portage Biotech Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-31	CI
Portage Biotech Inc. Announces First Patient Dosed in Phase 1A Trial of Portage-6 in Select Solid Tumors	23-06-26	CI
Portage Biotech Reports Updated Interim Data for Lead Inkt Engager, Port-2, in A Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer At the 2023 American Society for Clinical Oncology Annual Meeting	23-06-05	CI
Portage Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-03-01	CI
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-29	CI
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-29	CI
Portage Biotech Inc. Presents Updated Data on the Phase 1/2 Trial Evaluating Port-2 At the Society for Immunotherapy of Cancer’S 37Th Annual Meeting	22-11-10	CI
Portage Biotech, Merck to Collaborate on Cancer Study	22-11-08	MT
Portage Biotech Inc. Announces Clinical Trial Collaboration Agreement with Merck	22-11-08	CI
Portage Biotech Inc. Provides Research and Development Update	22-09-14	CI
Portage Biotech Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Highlights

Filters